(2023)
Risk factors for the failure of first-line PARP inhibitor maintenance therapy in patients with advanced ovarian cancer: Gynecologic Oncology Research Investigators Collaboration Study (GORILLA-3004).
CANCER MEDICINE.
12,
19
(2023)
Is minimally invasive radical surgery safe for patients with cervical cancer ≤2 cm in size? (MISAFE): Gynecologic Oncology Research Investigators coLLborAtion study (GORILLA-1003).
GYNECOLOGIC ONCOLOGY.
176,
(2023)
A prospective randomized controlled trial evaluating the safety and efficacy of patient blood management program in patients with gynecologic cancer (KGOG 4011/PBM).
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER.
33,
7
(2023)
Fertility-sparing hormonal treatment in patients with stage I endometrial cancer of grade 2 without myometrial invasion and grade 1–2 with superficial myometrial invasion: Gynecologic Oncology Research Investigators coLLaborAtion study (GORILLA-2001).
GYNECOLOGIC ONCOLOGY.
174,
(2023)
Efficacy of the PRO-CTCAE mobile application for improving patient participation in symptom management during cancer treatment: a randomized controlled trial.
SUPPORTIVE CARE IN CANCER.
31,
6
(2023)
The effect of adding chewing gum to oral carbohydrates on preoperative anxiety scores in women undergoing gynecological surgery: A randomized controlled study.
PLOS ONE.
18,
4
(2023)
Major clinical research advances in gynecologic cancer in 2022: highlight on late-line PARP inhibitor withdrawal in ovarian cancer, the impact of ARIEL-4, and SOLO-3.
JOURNAL OF GYNECOLOGIC ONCOLOGY.
34,
2
(2023)
Role of salvage radiotherapy for recurrent ovarian cancer.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER.
33,
1
(2022)
Invisible cervical cancers on MRI: Can the type of histology (SCC versus non-SCC) influence surgical planning?.
FRONTIERS IN ONCOLOGY.
12,
-
(2022)
Patterns and risk factors of recurrence in low-risk early-stage cervical adenocarcinoma treated with surgery alone: implications on risk group stratification.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER.
32,
12
(2022)
The impact of interval between primary cytoreductive surgery with bowel resection and initiation of adjuvant chemotherapy on survival of women with advanced ovarian cancer: a multicenter cohort study.
JOURNAL OF GYNECOLOGIC ONCOLOGY.
33,
6
(2022)
Does para-aortic lymphadenectomy improve survival in pathologically diagnosed early-stage grade 3 endometrioid and non-endometrioid endometrial cancers? A retrospective cohort study in Korea and Taiwan.
GYNECOLOGIC ONCOLOGY.
167,
1
(2022)
Role of reactive thrombocytosis after primary cytoreductive surgery in advanced ovarian cancer.
FRONTIERS IN ONCOLOGY.
12,
(2022)
Changes in subcellular localization of Lysyl-tRNA synthetase and the 67-kDa laminin receptor in epithelial ovarian cancer metastases.
CANCER BIOMARKERS.
35,
1
(2022)
The Role of Conization before Radical Hysterectomy in Cervical Cancer including High Risk Factors of Recurrence: Propensity Score Matching.
CANCERS.
14,
16
(2022)
Diagnostic Accuracy of Loop-Mediated Isothermal Amplification Assay for Group B Streptococcus Detection in Recto-Vaginal Swab: Comparison with Polymerase Chain Reaction Test and Conventional Culture.
DIAGNOSTICS.
12,
7
(2022)
Impact of no residual disease on postoperative computed tomography on survival in patients with optimally debulked advanced high-grade serous ovarian cancer during upfront surgery.
GYNECOLOGIC ONCOLOGY.
165,
3
(2022)
Prognostic Significance of HER3 Expression in Patients with Cervical Cancer.
CANCERS.
14,
9
(2022)
Awareness of genetic counseling and genetic testing for hereditary gynecologic cancers among Korean healthcare providers: A survey.
JOURNAL OF GENETIC COUNSELING.
31,
2
(2022)
Safety and efficacy study of laparoscopic or robotic radical surgery using an endoscopic stapler for inhibiting tumour spillage of cervical malignant neoplasms evaluating survival (SOLUTION): a multi-centre, open-label, single-arm, phase II trial protocol.
BMC CANCER.
22,
1
